M H Chin1, L Goldman. 1. Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA.
Abstract
OBJECTIVES: This study identifies acute precipitants of hospitalization and evaluates utilization of angiotension-converting enzyme inhibitors in patients admitted with congestive heart failure. METHODS: Cross-sectional chart-review study was done of 435 patients admitted nonelectively from February 1993 to February 1994 to an urban university hospital with a complaint of shortness of breath or fatigue and evidence of congestive heart failure. RESULTS: The most common identifiable abnormalities associated with clinical deterioration prior to admission were acute anginal chest pain (33%), respiratory infection (16%), uncontrolled hypertension with initial systolic blood pressure > or = 180 mm Hg (15%), atrial arrhythmia with heart rate > or = 120 (8%), and noncompliance with medications (15%) or diet (6%); in 34% of patients, no clear cause could be identified. After exclusion of those who were already on a different vasodilator or who had relative contraindications, 18 (32%) of the patients with ejection fractions < or = 0.35 measured prior to admission were not taking an angiotensin-converting enzyme inhibitor on presentation to the hospital. CONCLUSIONS: Interventions to improve compliance, the control of hypertension, and the appropriate use of angiotensin-converting enzyme inhibitors may prevent many hospitalizations of heart-failure patients.
OBJECTIVES: This study identifies acute precipitants of hospitalization and evaluates utilization of angiotension-converting enzyme inhibitors in patients admitted with congestive heart failure. METHODS: Cross-sectional chart-review study was done of 435 patients admitted nonelectively from February 1993 to February 1994 to an urban university hospital with a complaint of shortness of breath or fatigue and evidence of congestive heart failure. RESULTS: The most common identifiable abnormalities associated with clinical deterioration prior to admission were acute anginal chest pain (33%), respiratory infection (16%), uncontrolled hypertension with initial systolic blood pressure > or = 180 mm Hg (15%), atrial arrhythmia with heart rate > or = 120 (8%), and noncompliance with medications (15%) or diet (6%); in 34% of patients, no clear cause could be identified. After exclusion of those who were already on a different vasodilator or who had relative contraindications, 18 (32%) of the patients with ejection fractions < or = 0.35 measured prior to admission were not taking an angiotensin-converting enzyme inhibitor on presentation to the hospital. CONCLUSIONS: Interventions to improve compliance, the control of hypertension, and the appropriate use of angiotensin-converting enzyme inhibitors may prevent many hospitalizations of heart-failurepatients.
Authors: C Opasich; O Febo; P G Riccardi; E Traversi; G Forni; G Pinna; M Pozzoli; R Riccardi; A Mortara; M Sanarico; F Cobelli; L Tavazzi Journal: Am J Cardiol Date: 1996-08-01 Impact factor: 2.778
Authors: J B Young; D H Weiner; S Yusuf; C M Pratt; J B Kostis; M B Weiss; E Schroeder; M Guillote Journal: South Med J Date: 1995-05 Impact factor: 0.954
Authors: Hyo Jung Tak; Li-Wu Chen; Fernando A Wilson; Andrew M Goldsweig; Dmitry Oleynikov; Michael Hawking; Ya-Chen Tina Shih Journal: J Gen Intern Med Date: 2019-06-21 Impact factor: 5.128
Authors: Eric J Velazquez; Judson B Williams; Eric Yow; Linda K Shaw; Kerry L Lee; Harry R Phillips; Christopher M O'Connor; Peter K Smith; Robert H Jones Journal: Ann Thorac Surg Date: 2012-02 Impact factor: 4.330
Authors: Ali Ahmed; Richard M Allman; Gregg C Fonarow; Thomas E Love; Faiez Zannad; Louis J Dell'italia; Michel White; Mihai Gheorghiade Journal: J Card Fail Date: 2008-04 Impact factor: 5.712
Authors: Richard Lowrie; Lina Johansson; Paul Forsyth; Stuart Lochhead Bryce; Susan McKellar; Niamh Fitzgerald Journal: Int J Clin Pharm Date: 2013-11-30